Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women

Background: Controlled pharmacokinetic (PK) studies in United States populations have defined categories of tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) for various pre-exposure prophylaxis (PrEP) adherence targets. It is unknown how these categories perform in other populations. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyra, Maria, Anderson, Pete, Haberer, Jessica E., Heffron, Renee, Celum, Connie, Asiimwe, Stephen, Katabira, Elly, Mugo, Nelly R., Bukusi, Elizabeth A., Baeten, Jared M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478885/
https://www.ncbi.nlm.nih.gov/pubmed/31057407
http://dx.doi.org/10.3389/fphar.2019.00401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478885/
https://www.ncbi.nlm.nih.gov/pubmed/31057407
http://dx.doi.org/10.3389/fphar.2019.00401

Ejemplares similares